ICMRA, the International Coalition of Medicines Regulatory Authorities, is a global organization that provides an architecture for enhanced communication, information sharing, crisis response, and regulatory science. With a focus on addressing regulatory science issues, ICMRA plays a crucial role in ensuring the safety and efficacy of medicines worldwide. Through their strategic initiatives, ICMRA tackles important areas such as antimicrobial resistance, capacity building, communication, crisis management, innovation, and pharmaceutical quality.

They also prioritize knowledge management, pharmacovigilance, and supply chain integrity. By bringing together regulatory authorities from around the world, ICMRA promotes collaboration and harmonization of standards to strengthen global healthcare systems. ICMRA hosts various meetings and summits, allowing regulatory authorities to discuss and address key challenges and developments.

They also publish news updates and reports on their website, keeping stakeholders informed about important industry topics. With its dedication to advancing regulatory science and promoting global health, ICMRA remains at the forefront of ensuring that medicines meet the highest standards of safety and efficacy